- Home
- BLTE
BLTE
Belite Bio Inc
as 07-26-2024 4:00pm EST
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 1.5B | IPO Year: | 2022 |
| Target Price: | $50.25 | AVG Volume (30 days): | 44.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $20.32 - $50.66 | Next Earning Date: | 08-06-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Belite Bio Inc News
BLTE Breaking Stock News: Dive into BLTE Ticker-Specific Updates for Smart Investing
GlobeNewswire
18 days ago
Belite Bio to Present at the JonesHealthcare Seaside Summit
Simply Wall St.
a month ago
Estimating The Intrinsic Value Of Belite Bio, Inc (NASDAQ:BLTE)
MT Newswires
a month ago
Belite Bio Obtains Pioneer Drug Designation for Stargardt Disease Treatment in Japan
GlobeNewswire
a month ago
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan
GlobeNewswire
2 months ago
Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
MT Newswires
2 months ago
Belite Bio's Q1 Loss Narrows
GlobeNewswire
2 months ago
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2 months ago
Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
Compare BLTE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BLTE Belite Bio Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.